NCT02621866 is a NA clinical trial of Ultraviolet A radiation in Hypertension, sponsored by University of Edinburgh.

Who is sponsoring NCT02621866?

NCT02621866 is sponsored by University of Edinburgh.

What drugs are being tested in NCT02621866?

Interventions in NCT02621866: Ultraviolet A radiation, Sham irradiation.

What condition does NCT02621866 study?

NCT02621866 studies Hypertension.

Is NCT02621866 still recruiting?

NCT02621866 is currently terminated. Last updated 13 May 2024.

Last reviewed 2024-05-13 · How we verify

NCT02621866

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Trial of Daily Ultraviolet Therapy to Reduce Cardiovascular Risk Factors

Terminated NA Last updated 13 May 2024

What this trial tests

NA trial testing Ultraviolet A radiation in Hypertension in 13 participants. Terminated before completion.

Timeline

2 May 2017

Primary endpoint
31 August 2019

31 August 2019

Quick facts

Lead sponsor	University of Edinburgh
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	treatment
Enrollment	13
Start date	2 May 2017
Primary completion	31 August 2019
Estimated completion	31 August 2019
Sites	1 location across United Kingdom

Drugs / interventions tested

Ultraviolet A radiation
Sham irradiation

Conditions studied

Hypertension — all drugs for Hypertension →

Sponsor

University of Edinburgh

Who can join

16 and older, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators have shown that a single dose of ultraviolet irradiation (as found in sunlight) will lower blood pressure for around one hour. They are now testing whether daily UVA for two weeks will produce a sustained fall in BP in patients with high blood pressure. They will also measure the effect of daily UVA on other cardiovascular risk factors.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The effect of daily UVA phototherapy for 2 weeks on clinic and 24-h blood pressure in individuals with mild hypertension.
Weller RB, Macintyre IM, Melville V, Farrugia M, et al · · 2023 · cited 6× · PMID 35931819 · DOI 10.1038/s41371-022-00729-2
Solar UV Radiation: A Potential Modifiable Risk Factor for Hypertension.
Kapil V, Gupta AK. · · 2020 · cited 3× · PMID 32106745 · DOI 10.1161/jaha.120.015627

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting

Other University of Edinburgh trials

Trials by the same sponsor.

NCT07341126 — Use of a Novel Camera to Check the Bowel After Polyp or Tumour Removal · not yet recruiting
NCT07523997 — Imaging of Endometriosis With Total-body PET-CT (PET-Endo) · not yet recruiting
NCT07430540 — Optimising Colorectal Cancer Patient Pathways · NA · not yet recruiting
NCT07430527 — Secondary Care Colorectal Cancer Pathway Review · not yet recruiting
NCT07436026 — Latin America Network for Primary Palliative Care · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02621866 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Edinburgh
Last refreshed: 13 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02621866.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing